Regulatory snapshots, including drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations in Asia-Pacific: Antengene, Ascletis, Biontech, Bioxytran, Brim, Cerecin, Curadev, Delta-Fly, Hexaell, Liscure, Moderna, Novavax, Pfizer, Recce, Takeda.